Ashman LK - Search Results

1

KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?

Fletcher JA, Fletcher CD, Rubin BP, Ashman LK, Corless CL, Heinrich MC. Fletcher JA, et al. Among authors: ashman lk. Am J Pathol. 2002 Aug;161(2):737-8; author reply 738-9. doi: 10.1016/S0002-9440(10)64229-0. Am J Pathol. 2002. PMID: 12163398 Free PMC article. No abstract available.

2

Effects of mutant c-kit in early myeloid cells.

Ashman LK, Ferrao P, Cole SR, Cambareri AC. Ashman LK, et al. Leuk Lymphoma. 2000 Mar;37(1-2):233-43. doi: 10.3109/10428190009057652. Leuk Lymphoma. 2000. PMID: 10721793

3

Human osteoclasts and preosteoclast cells (FLG 29.1) express functional c-kit receptors and interact with osteoblast and stromal cells via membrane-bound stem cell factor.

Gattei V, Aldinucci D, Quinn JM, Degan M, Cozzi M, Perin V, Iuliis AD, Juzbasic S, Improta S, Athanasou NA, Ashman LK, Pinto A. Gattei V, et al. Among authors: ashman lk. Cell Growth Differ. 1996 Jun;7(6):753-63. Cell Growth Differ. 1996. PMID: 8780889

4

Effects of mutant c-Kit in early myeloid cells.

Ashman LK, Ferrao P, Cole SR, Cambareri AC. Ashman LK, et al. Leuk Lymphoma. 1999 Aug;34(5-6):451-61. doi: 10.3109/10428199909058472. Leuk Lymphoma. 1999. Corrected and republished in: Leuk Lymphoma. 2000 Mar;37(1-2):233-43. doi: 10.3109/10428190009057652 PMID: 10492068 Corrected and republished. Review.

5

Therapeutic targeting of c-KIT in cancer.

Ashman LK, Griffith R. Ashman LK, et al. Expert Opin Investig Drugs. 2013 Jan;22(1):103-15. doi: 10.1517/13543784.2013.740010. Epub 2012 Nov 6. Expert Opin Investig Drugs. 2013. PMID: 23127174 Review.

6

Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line.

Kanakura Y, Furitsu T, Tsujimura T, Butterfield JH, Ashman LK, Ikeda H, Kitayama H, Kanayama Y, Matsuzawa Y, Kitamura Y. Kanakura Y, et al. Among authors: ashman lk. Leukemia. 1994 Apr;8 Suppl 1:S18-22. Leukemia. 1994. PMID: 7512180

7

The biology of stem cell factor and its receptor C-kit.

Ashman LK. Ashman LK. Int J Biochem Cell Biol. 1999 Oct;31(10):1037-51. doi: 10.1016/s1357-2725(99)00076-x. Int J Biochem Cell Biol. 1999. PMID: 10582338 Review.

8

Transformation of NIH3T3 fibroblasts by the c-Kit receptor tyrosine kinase: effect of receptor density and ligand-requirement.

Caruana G, Cambareri AC, Gonda TJ, Ashman LK. Caruana G, et al. Among authors: ashman lk. Oncogene. 1998 Jan 15;16(2):179-90. doi: 10.1038/sj.onc.1201494. Oncogene. 1998. PMID: 9464535

9

Specificity and functional effects of antibodies to human stem cell factor.

Zannettino AC, Aylett GW, Leavesley DI, Pietsch T, Chang DG, Simmons PJ, Ashman LK. Zannettino AC, et al. Among authors: ashman lk. Growth Factors. 1997;14(1):67-79. doi: 10.3109/08977199709021511. Growth Factors. 1997. PMID: 9086329

10

Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia.

Ferrao P, Sincock P, Cole S, Ashman L. Ferrao P, et al. Leuk Res. 2001 May;25(5):395-405. doi: 10.1016/s0145-2126(00)00156-9. Leuk Res. 2001. PMID: 11301107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters